Fundraising FoxTenapanor
1 known investors
Find your way into Tenapanor
Sign up to see every warm intro you have to Tenapanor
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tenapanor team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
IBSRELA is a prescription medication containing tenapanor designed to treat irritable bowel syndrome with constipation (IBS-C) in adults by reducing constipation and abdominal pain. The drug works by increasing intestinal water retention, supporting gut lining integrity, and reducing pain-sensing nerve sensitivity.
Investors · 1
Frequently asked questions
- What does Tenapanor do?
- IBSRELA is a prescription medication containing tenapanor designed to treat irritable bowel syndrome with constipation (IBS-C) in adults by reducing constipation and abdominal pain. The drug works by increasing intestinal water retention, supporting gut lining integrity, and reducing pain-sensing nerve sensitivity.
- Who are Tenapanor's investors?
- Tenapanor's investors include HEALTHCARE ROYALTY PARTNERS.